FGF19-FGFR4 axis as the inaugural target for determining the efficacy of advanced esophageal cancer treatment.
Sign Up to like & getrecommendations! Published in 2024 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2024.42.16_suppl.4035
Abstract: 4035 Background: Advanced esophageal cancer (EC) remains a fatal stage with limited survival benefits from current treatments due to lack of specific targets. Esophageal squamous cell carcinoma (ESCC) is the most common type observed in… read more here.
Keywords: cancer; fgf19 fgfr4; anlotinib based; fgf19 amplifications ... See more keywords